Xvivo Perfusion Financials

Xvivo Perfusion Stock Summary

Xvivo Perfusion competes with Bone Biologics, and Tenon Medical. Xvivo Perfusion AB , a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation in Sweden, the United States, North America and South America, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 1998 and is headquartered in Gothenburg, Sweden. Xvivo Perfusion operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 115 people.

Xvivo Perfusion Key Financial Ratios

There are many critical financial ratios that Xvivo Perfusion's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Xvivo Perfusion AB reports annually and quarterly.

Xvivo Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Xvivo Perfusion's current stock value. Our valuation model uses many indicators to compare Xvivo Perfusion value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Xvivo Perfusion competition to find correlations between indicators driving Xvivo Perfusion's intrinsic value. More Info.Xvivo Perfusion AB is rated first in return on equity category among its peers. It is rated first in return on asset category among its peers reporting about  0.42  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Xvivo Perfusion AB is roughly  2.39 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Xvivo Perfusion's earnings, one of the primary drivers of an investment's value.

Xvivo Perfusion AB Systematic Risk

Along with financial statement analysis, the daily predictive indicators of Xvivo Perfusion help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Xvivo Perfusion AB. We use our internally-developed statistical techniques to arrive at the intrinsic value of Xvivo Perfusion AB based on widely used predictive technical indicators. In general, we focus on analyzing Xvivo Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Xvivo Perfusion's daily price indicators and compare them against related drivers.

When running Xvivo Perfusion's price analysis, check to measure Xvivo Perfusion's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xvivo Perfusion is operating at the current time. Most of Xvivo Perfusion's value examination focuses on studying past and present price action to predict the probability of Xvivo Perfusion's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xvivo Perfusion's price. Additionally, you may evaluate how the addition of Xvivo Perfusion to your portfolios can decrease your overall portfolio volatility.